[2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-4-pyridinyl] 3-(2H-imidazol-4-yl)propanoate
C22H23N5O4S — CID 163457755
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-4-pyridinyl] 3-(2H-imidazol-4-yl)propanoate
[2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-4-pyridinyl] 3-(2H-imidazol-4-yl)propanoate (PubChem CID 163457755) has the molecular formula C22H23N5O4S and a molecular weight of 453.52 g/mol. Its IUPAC name is [2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-4-pyridinyl] 3-(2H-imidazol-4-yl)propanoate.
Molecular Properties
| Compound Name | [2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-4-pyridinyl] 3-(2H-imidazol-4-yl)propanoate |
|---|---|
| PubChem CID | 163457755 |
| Molecular Formula | C22H23N5O4S |
| Molecular Weight | 453.52 g/mol |
| Exact Mass | 453.15 |
| IUPAC Name | [2-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-3,5-dimethyl-4-pyridinyl] 3-(2H-imidazol-4-yl)propanoate |
| SMILES | COc1ccc2nc(S(=O)Cc3ncc(C)c(OC(=O)CCC4=NCN=C4)c3C)[nH]c2c1 |
| InChI | InChI=1S/C22H23N5O4S/c1-13-9-24-19(14(2)21(13)31-20(28)7-4-15-10-23-12-25-15)11-32(29)22-26-17-6-5-16(30-3)8-18(17)27-22/h5-6,8-10H,4,7,11-12H2,1-3H3,(H,26,27) |
| InChIKey | BLXNBLQHRXDTCP-UHFFFAOYSA-N |
| XLogP | 3.06 |
| TPSA | 118.89 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.52 |
| LogP ≤ 5 | 3.06 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163457755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.